Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desloratadine + Prednisolone in acute cutaneous rash
NCT01529242Phase 3Terminated
- Sponsor
- EMS
- Start
- Feb 2014
- Primary completion
- Aug 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of desloratadine, prednisolone, sponsored by EMS. Started Feb 2014; status: terminated.
02
Drugs
desloratadineprednisolone
Beyond the preview
Go deeper on NCT01529242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01529242.